Cholinergic control of inflammation
. Cytokine production is necessary to protect against pathogens and promote tissue repair, but excessive cytokine release can lead to systemic inflammation, organ failure and death. Inflammatory responses are finely regulated to effectively guard from noxious stimuli. The central nervous system inte...
Gespeichert in:
Veröffentlicht in: | Journal of internal medicine 2009-06, Vol.265 (6), p.663-679 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 679 |
---|---|
container_issue | 6 |
container_start_page | 663 |
container_title | Journal of internal medicine |
container_volume | 265 |
creator | Rosas‐Ballina, M. Tracey, K. J. |
description | .
Cytokine production is necessary to protect against pathogens and promote tissue repair, but excessive cytokine release can lead to systemic inflammation, organ failure and death. Inflammatory responses are finely regulated to effectively guard from noxious stimuli. The central nervous system interacts dynamically with the immune system to modulate inflammation through humoral and neural pathways. The effect of glucocorticoids and other humoral mediators on inflammatory responses has been studied extensively in the past decades. In contrast, neural control of inflammation has only been recently described. We summarize autonomic regulation of local and systemic inflammation through the ‘cholinergic anti‐inflammatory pathway’, a mechanism consisting of the vagus nerve and its major neurotransmitter, acetylcholine, a process dependent on the nicotinic acetylcholine receptor α7 subunit. We recapitulate additional sources of acetylcholine and their contribution to the inflammatory response, as well as acetylcholine regulation by acetylcholinesterase as a means to attenuate inflammation. We discuss potential therapeutic applications to treat diseases characterized by acute or chronic inflammation, including autoimmune diseases, and propose future research directions. |
doi_str_mv | 10.1111/j.1365-2796.2009.02098.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4540232</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67323775</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5698-69aa6405a822cff984e97c8863b4d79ad035c3f0203f9bbde3085bcd5b0c1ee53</originalsourceid><addsrcrecordid>eNqNkMtOwzAQRS0EgvL4BVQJwS5hbMeOvUFCFU-B2MDachy7uHJiiFsef09CqwI7vPFIc-fOnYPQGEOO-3c6yzHlLCOl5DkBkDkQkCL_2ECjdWMTjUCyIuOCwA7aTWkGgClw2EY7WBZyKEfoaPIcg29tN_VmbGI772IYRzf2rQu6afTcx3YfbTkdkj1Y_Xvo6fLicXKd3T1c3UzO7zLDuBQZl1rzApgWhBjnpCisLI0QnFZFXUpdA2WGuj4qdbKqaktBsMrUrAKDrWV0D50tfV8WVWNrY_s0OqiXzje6-1RRe_W30_pnNY1vqmAFEEp6g5OVQRdfFzbNVeOTsSHo1sZFUrzsRWU5bBJLoeliSp116yUY1EBYzdQAUg0g1UBYfRNWH_3o4e-QP4MrpL3geCXQyejgOt0an9Y6gguKBfl17bsP9vPfAdTtw839UNIvxO6XjA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67323775</pqid></control><display><type>article</type><title>Cholinergic control of inflammation</title><source>MEDLINE</source><source>IngentaConnect Open Access Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley Online Library Free Content</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Rosas‐Ballina, M. ; Tracey, K. J.</creator><creatorcontrib>Rosas‐Ballina, M. ; Tracey, K. J.</creatorcontrib><description>.
Cytokine production is necessary to protect against pathogens and promote tissue repair, but excessive cytokine release can lead to systemic inflammation, organ failure and death. Inflammatory responses are finely regulated to effectively guard from noxious stimuli. The central nervous system interacts dynamically with the immune system to modulate inflammation through humoral and neural pathways. The effect of glucocorticoids and other humoral mediators on inflammatory responses has been studied extensively in the past decades. In contrast, neural control of inflammation has only been recently described. We summarize autonomic regulation of local and systemic inflammation through the ‘cholinergic anti‐inflammatory pathway’, a mechanism consisting of the vagus nerve and its major neurotransmitter, acetylcholine, a process dependent on the nicotinic acetylcholine receptor α7 subunit. We recapitulate additional sources of acetylcholine and their contribution to the inflammatory response, as well as acetylcholine regulation by acetylcholinesterase as a means to attenuate inflammation. We discuss potential therapeutic applications to treat diseases characterized by acute or chronic inflammation, including autoimmune diseases, and propose future research directions.</description><identifier>ISSN: 0954-6820</identifier><identifier>EISSN: 1365-2796</identifier><identifier>DOI: 10.1111/j.1365-2796.2009.02098.x</identifier><identifier>PMID: 19493060</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Acetylcholine - immunology ; alpha7 ; Animals ; Biological and medical sciences ; Brain - metabolism ; cholinergic ; Cholinergic Agents - immunology ; General aspects ; inflammation ; Inflammation - immunology ; innate immunity ; Medical sciences ; Mice ; Mice, Knockout ; Neural Pathways - metabolism ; Receptors, Cholinergic - immunology ; Receptors, Cholinergic - metabolism ; Receptors, Nicotinic - metabolism ; Sepsis - immunology ; Tumor Necrosis Factor-alpha - metabolism ; Vagus Nerve - immunology ; Vagus Nerve - physiology</subject><ispartof>Journal of internal medicine, 2009-06, Vol.265 (6), p.663-679</ispartof><rights>2009 Blackwell Publishing Ltd</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5698-69aa6405a822cff984e97c8863b4d79ad035c3f0203f9bbde3085bcd5b0c1ee53</citedby><cites>FETCH-LOGICAL-c5698-69aa6405a822cff984e97c8863b4d79ad035c3f0203f9bbde3085bcd5b0c1ee53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2796.2009.02098.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2796.2009.02098.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,309,310,314,776,780,785,786,881,1411,1427,23909,23910,25118,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21431825$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19493060$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rosas‐Ballina, M.</creatorcontrib><creatorcontrib>Tracey, K. J.</creatorcontrib><title>Cholinergic control of inflammation</title><title>Journal of internal medicine</title><addtitle>J Intern Med</addtitle><description>.
Cytokine production is necessary to protect against pathogens and promote tissue repair, but excessive cytokine release can lead to systemic inflammation, organ failure and death. Inflammatory responses are finely regulated to effectively guard from noxious stimuli. The central nervous system interacts dynamically with the immune system to modulate inflammation through humoral and neural pathways. The effect of glucocorticoids and other humoral mediators on inflammatory responses has been studied extensively in the past decades. In contrast, neural control of inflammation has only been recently described. We summarize autonomic regulation of local and systemic inflammation through the ‘cholinergic anti‐inflammatory pathway’, a mechanism consisting of the vagus nerve and its major neurotransmitter, acetylcholine, a process dependent on the nicotinic acetylcholine receptor α7 subunit. We recapitulate additional sources of acetylcholine and their contribution to the inflammatory response, as well as acetylcholine regulation by acetylcholinesterase as a means to attenuate inflammation. We discuss potential therapeutic applications to treat diseases characterized by acute or chronic inflammation, including autoimmune diseases, and propose future research directions.</description><subject>Acetylcholine - immunology</subject><subject>alpha7</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Brain - metabolism</subject><subject>cholinergic</subject><subject>Cholinergic Agents - immunology</subject><subject>General aspects</subject><subject>inflammation</subject><subject>Inflammation - immunology</subject><subject>innate immunity</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>Neural Pathways - metabolism</subject><subject>Receptors, Cholinergic - immunology</subject><subject>Receptors, Cholinergic - metabolism</subject><subject>Receptors, Nicotinic - metabolism</subject><subject>Sepsis - immunology</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><subject>Vagus Nerve - immunology</subject><subject>Vagus Nerve - physiology</subject><issn>0954-6820</issn><issn>1365-2796</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkMtOwzAQRS0EgvL4BVQJwS5hbMeOvUFCFU-B2MDachy7uHJiiFsef09CqwI7vPFIc-fOnYPQGEOO-3c6yzHlLCOl5DkBkDkQkCL_2ECjdWMTjUCyIuOCwA7aTWkGgClw2EY7WBZyKEfoaPIcg29tN_VmbGI772IYRzf2rQu6afTcx3YfbTkdkj1Y_Xvo6fLicXKd3T1c3UzO7zLDuBQZl1rzApgWhBjnpCisLI0QnFZFXUpdA2WGuj4qdbKqaktBsMrUrAKDrWV0D50tfV8WVWNrY_s0OqiXzje6-1RRe_W30_pnNY1vqmAFEEp6g5OVQRdfFzbNVeOTsSHo1sZFUrzsRWU5bBJLoeliSp116yUY1EBYzdQAUg0g1UBYfRNWH_3o4e-QP4MrpL3geCXQyejgOt0an9Y6gguKBfl17bsP9vPfAdTtw839UNIvxO6XjA</recordid><startdate>200906</startdate><enddate>200906</enddate><creator>Rosas‐Ballina, M.</creator><creator>Tracey, K. J.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200906</creationdate><title>Cholinergic control of inflammation</title><author>Rosas‐Ballina, M. ; Tracey, K. J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5698-69aa6405a822cff984e97c8863b4d79ad035c3f0203f9bbde3085bcd5b0c1ee53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Acetylcholine - immunology</topic><topic>alpha7</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Brain - metabolism</topic><topic>cholinergic</topic><topic>Cholinergic Agents - immunology</topic><topic>General aspects</topic><topic>inflammation</topic><topic>Inflammation - immunology</topic><topic>innate immunity</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>Neural Pathways - metabolism</topic><topic>Receptors, Cholinergic - immunology</topic><topic>Receptors, Cholinergic - metabolism</topic><topic>Receptors, Nicotinic - metabolism</topic><topic>Sepsis - immunology</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><topic>Vagus Nerve - immunology</topic><topic>Vagus Nerve - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rosas‐Ballina, M.</creatorcontrib><creatorcontrib>Tracey, K. J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of internal medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rosas‐Ballina, M.</au><au>Tracey, K. J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cholinergic control of inflammation</atitle><jtitle>Journal of internal medicine</jtitle><addtitle>J Intern Med</addtitle><date>2009-06</date><risdate>2009</risdate><volume>265</volume><issue>6</issue><spage>663</spage><epage>679</epage><pages>663-679</pages><issn>0954-6820</issn><eissn>1365-2796</eissn><abstract>.
Cytokine production is necessary to protect against pathogens and promote tissue repair, but excessive cytokine release can lead to systemic inflammation, organ failure and death. Inflammatory responses are finely regulated to effectively guard from noxious stimuli. The central nervous system interacts dynamically with the immune system to modulate inflammation through humoral and neural pathways. The effect of glucocorticoids and other humoral mediators on inflammatory responses has been studied extensively in the past decades. In contrast, neural control of inflammation has only been recently described. We summarize autonomic regulation of local and systemic inflammation through the ‘cholinergic anti‐inflammatory pathway’, a mechanism consisting of the vagus nerve and its major neurotransmitter, acetylcholine, a process dependent on the nicotinic acetylcholine receptor α7 subunit. We recapitulate additional sources of acetylcholine and their contribution to the inflammatory response, as well as acetylcholine regulation by acetylcholinesterase as a means to attenuate inflammation. We discuss potential therapeutic applications to treat diseases characterized by acute or chronic inflammation, including autoimmune diseases, and propose future research directions.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>19493060</pmid><doi>10.1111/j.1365-2796.2009.02098.x</doi><tpages>17</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0954-6820 |
ispartof | Journal of internal medicine, 2009-06, Vol.265 (6), p.663-679 |
issn | 0954-6820 1365-2796 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4540232 |
source | MEDLINE; IngentaConnect Open Access Journals; Wiley Online Library Journals Frontfile Complete; Wiley Online Library Free Content; EZB-FREE-00999 freely available EZB journals |
subjects | Acetylcholine - immunology alpha7 Animals Biological and medical sciences Brain - metabolism cholinergic Cholinergic Agents - immunology General aspects inflammation Inflammation - immunology innate immunity Medical sciences Mice Mice, Knockout Neural Pathways - metabolism Receptors, Cholinergic - immunology Receptors, Cholinergic - metabolism Receptors, Nicotinic - metabolism Sepsis - immunology Tumor Necrosis Factor-alpha - metabolism Vagus Nerve - immunology Vagus Nerve - physiology |
title | Cholinergic control of inflammation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T00%3A02%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cholinergic%20control%20of%20inflammation&rft.jtitle=Journal%20of%20internal%20medicine&rft.au=Rosas%E2%80%90Ballina,%20M.&rft.date=2009-06&rft.volume=265&rft.issue=6&rft.spage=663&rft.epage=679&rft.pages=663-679&rft.issn=0954-6820&rft.eissn=1365-2796&rft_id=info:doi/10.1111/j.1365-2796.2009.02098.x&rft_dat=%3Cproquest_pubme%3E67323775%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67323775&rft_id=info:pmid/19493060&rfr_iscdi=true |